Physician profile
Danielle L Mace
NPI 1609208743
$823.13
in general payments reported to CMS, 2019-2025
7 companies · $556 in 2025
The $556 reported for 2025 was more than what 91% of General Practice (Dentist) providers received nationally (typical 2025 total: $74.60).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $35.25 · 2021: $116 · 2023: $51.67 · 2024: $63.73 · 2025: $556.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $672.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $671.54 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Revance Therapeutics, INC. | $541.37 | 2025 | Daxxify |
| Implant Direct Sybron International LLC | $116.34 | 2021 | |
| Align Technology, INC. | $67.16 | 2023-2025 | Invisalign, Itero Element 5d Plus, Invisalign Go |
| Hu-Friedy Mfg. Co., LLC | $41.33 | 2024 | |
| Henry Schein, INC. | $35.25 | 2019 | |
| Colgate Oral Pharmaceuticals, INC. | $14.26 | 2023 | |
| Ultradent Products INC | $7.42 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Danielle Mace listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.